Applications of donor-derived cell-free DNA in kidney transplantation healthcare: view from a prospective single-center study
Phuong Thanh Nguyen, Hirofumi Nakaoka, Shigeki Mitsunaga, Hiromichi Aoyama, Hiroshi Kitamura, Kenichi Saigo, Ituro Inoue · 2026
Read Applications of donor-derived cell-free DNA in kidney transplantation healthcare: view from a prospective single-center study by Phuong Thanh Nguyen, Hirofumi Nakaoka, Shigeki Mitsunaga, Hiromichi Aoyama, Hiroshi Kitamura, Kenichi Saigo, Ituro Inoue (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518428.txt.
Description
Phuong Thanh Nguyen and others evaluate donor-derived cell-free DNA for kidney transplant tracking in a forward-looking single-center study. In 2026, the long-term study collects 322 blood samples from thirty-nine kidney recipients, most in the first year and up to five years post-transplant. It quantifies donor DNA with a modified aimed reading protocol using a 1,000-SNP panel tailored to East Asian backgrounds. Non-invasive rejection markers are urgently needed, since biopsy is invasive.
Raised donor-derived cell-free DNA consistently linked to acute rejection and graft injuries, clearly distinguishing rejection from non-rejection episodes and aligning moderately with serum markers and biopsies. Surges appeared in antibody-mediated rejection and various injuries. Unlike standard markers, donor DNA inversely correlated with immune-quieting trough levels, suggesting superior tracking of immune-quieting response.
Catalog record
| CREATOR | Phuong Thanh Nguyen, Hirofumi Nakaoka, Shigeki Mitsunaga, Hiromichi Aoyama, Hiroshi Kitamura, Kenichi Saigo, Ituro Inoue |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |